WO2008035369A3 - Novel form of o-desmethyl venlafaxine - Google Patents
Novel form of o-desmethyl venlafaxine Download PDFInfo
- Publication number
- WO2008035369A3 WO2008035369A3 PCT/IN2007/000266 IN2007000266W WO2008035369A3 WO 2008035369 A3 WO2008035369 A3 WO 2008035369A3 IN 2007000266 W IN2007000266 W IN 2007000266W WO 2008035369 A3 WO2008035369 A3 WO 2008035369A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- novel form
- desmethyl venlafaxine
- desmethyl
- venlafaxine
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Abstract
The present invention relates to novel crystalline polymorphic form of O-desmethyl venlafaxine which is designated as form A and process for the preparation of the same.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1048MU2006 | 2006-06-30 | ||
IN1048/MUM/2006 | 2006-06-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008035369A2 WO2008035369A2 (en) | 2008-03-27 |
WO2008035369A3 true WO2008035369A3 (en) | 2008-05-15 |
Family
ID=39106101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2007/000266 WO2008035369A2 (en) | 2006-06-30 | 2007-06-28 | Novel form of o-desmethyl venlafaxine |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008035369A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009027766A2 (en) * | 2006-12-22 | 2009-03-05 | Medichem, S.A. | New crystalline solid forms of o-desvenlafaxine base |
CN106995376A (en) * | 2017-04-21 | 2017-08-01 | 上海华源医药科技发展有限公司 | A kind of industrialized producing technology of desmethylvenlafaxine |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030105358A1 (en) * | 2001-12-04 | 2003-06-05 | Wyeth | Methods for preparing O-desmethylvenlafaxine |
WO2007071404A1 (en) * | 2005-12-20 | 2007-06-28 | Synthon B.V. | Process for making desvenlafaxine |
WO2007120923A1 (en) * | 2006-04-17 | 2007-10-25 | Teva Pharmaceutical Industries Ltd. | Substantially pure o-desmethylvenlafaxine and processes for preparing it |
US20080033051A1 (en) * | 2006-04-17 | 2008-02-07 | Sigalit Levi | Crystal forms of o-desmethylvenlafaxine |
-
2007
- 2007-06-28 WO PCT/IN2007/000266 patent/WO2008035369A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030105358A1 (en) * | 2001-12-04 | 2003-06-05 | Wyeth | Methods for preparing O-desmethylvenlafaxine |
WO2003048104A1 (en) * | 2001-12-04 | 2003-06-12 | Wyeth | Methods for preparing o-desmethylvenlafaxine |
WO2007071404A1 (en) * | 2005-12-20 | 2007-06-28 | Synthon B.V. | Process for making desvenlafaxine |
WO2007120923A1 (en) * | 2006-04-17 | 2007-10-25 | Teva Pharmaceutical Industries Ltd. | Substantially pure o-desmethylvenlafaxine and processes for preparing it |
US20080033051A1 (en) * | 2006-04-17 | 2008-02-07 | Sigalit Levi | Crystal forms of o-desmethylvenlafaxine |
Also Published As
Publication number | Publication date |
---|---|
WO2008035369A2 (en) | 2008-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009076142A3 (en) | Processes for producing cycloalkylcarboxiamido-pyridine benzoic acids | |
WO2011138281A3 (en) | Process for the preparation of dithiine tetracarboxydiimides | |
WO2009095933A3 (en) | Improved and novel process for the preparation of bosentan | |
WO2008089984A3 (en) | Process for the preparation of ezetimibe and derivatives thereof | |
SG170729A1 (en) | Processes and intermediates for preparing steric compounds | |
WO2010080242A3 (en) | Uzm-27 family of crystalline aluminosilicate compositions, a method of preparing the compositions and methods of using the compositions | |
WO2010062590A3 (en) | Process for the preparation of protected l-alanine derivatives | |
WO2010139981A3 (en) | Processes for preparing crystalline forms of dasatinib | |
WO2009077161A3 (en) | Method for producing fatty acid alkyl esters | |
WO2007120925A3 (en) | Crystal forms of o-desmethylvenlafaxine | |
WO2010070667A3 (en) | Process and intermediates for the preparation of 7-( (3-chloro-6-methyl-5,5-dioxo-6,ll-dihydrodibenzo (c, f) (1,2) thiazepin-11-yd amino) heptanoate | |
WO2010036329A3 (en) | Process for making quinolone compounds | |
WO2011004402A3 (en) | Improved process for the preparation of ambrisentan and novel intermediates thereof | |
WO2009053446A3 (en) | Pregabalin intermediates and process for preparing them and pregabalin | |
WO2011024192A3 (en) | Novel polymorphs of raltegravir | |
WO2010004578A3 (en) | Novel and improved processes for the preparation of paliperidone | |
WO2010015656A3 (en) | Alkoxypyrazoles and the process for their preparation | |
WO2007099552A3 (en) | Novel crystalline form of atovastatin hemi-magnesium | |
WO2007013043A3 (en) | Processes for the preparation of 7-amino-3-vinyl cephalosporanic acid | |
WO2011007136A3 (en) | Process for the preparation of o-desmethyl venlafaxine and intermediate for use therein | |
WO2008035369A3 (en) | Novel form of o-desmethyl venlafaxine | |
WO2008008327A3 (en) | Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound | |
WO2010023676A3 (en) | Process for preparing lamivudine polymorph form | |
WO2008007391A3 (en) | An improved process for the preparation of valsartan | |
WO2011061610A3 (en) | Processes for preparation of polymorphic forms of lacosamide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07859580 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07859580 Country of ref document: EP Kind code of ref document: A2 |